This is the bio for Alexis (Brekke) Pellek, assistant editor of Pharmaceutical Technology.
Alexis (Brekke) Pellek
Assistant editor
732.346.3079, apellek@advanstar.com
Alexis joined Pharmaceutical Technology in 2007. In addition to editing and writing for the monthly magazine, she serves as the site manager for PharmTech.com. Alexis also manages PharmTech Talk, the blog of Pharmaceutical Technology, and edits ePT, the weekly e-newsletter. Alexis has experience editing and writing for consumer magazines and newspapers, and holds a Master of Science in communication from the University of Tennessee, Knoxville.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.